Brevan Howard Capital Management LP Raises Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Brevan Howard Capital Management LP increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 218.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,338 shares of the company's stock after buying an additional 18,067 shares during the period. Brevan Howard Capital Management LP's holdings in Option Care Health were worth $611,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in shares of Option Care Health by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after buying an additional 344,875 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after purchasing an additional 14,311 shares in the last quarter. Graypoint LLC purchased a new position in Option Care Health in the 4th quarter valued at $1,161,000. Charles Schwab Investment Management Inc. lifted its holdings in Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after purchasing an additional 147,054 shares in the last quarter. Finally, Global Alpha Capital Management Ltd. lifted its holdings in Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after purchasing an additional 18,992 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is owned by insiders.

Option Care Health Trading Up 1.0%

Shares of NASDAQ OPCH traded up $0.33 during trading on Wednesday, hitting $31.89. 503,088 shares of the company were exchanged, compared to its average volume of 1,849,458. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a fifty day moving average price of $33.13 and a 200-day moving average price of $28.92. The firm has a market capitalization of $5.22 billion, a PE ratio of 26.80, a P/E/G ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.26 EPS. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on OPCH. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.